ScoreWhy is NeoGenomics, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -229.88% of over the last 5 years
2
Positive results in Dec 25
- RAW MATERIAL COST(Y) Fallen by 0.64% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 4.67 times
- NET SALES(Q) Highest at USD 190.17 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -22.64%, its profits have fallen by -8.7%
4
Rising Promoter Confidence
- Promoters have increased their stake in the company by 1.77% over the previous quarter and currently hold 3.44% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -22.64% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to NeoGenomics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NeoGenomics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
NeoGenomics, Inc.
-23.52%
-0.58
70.18%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.35%
EBIT Growth (5y)
-229.88%
EBIT to Interest (avg)
-38.77
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.48
Tax Ratio
1.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.28
EV to EBIT
-18.10
EV to EBITDA
-775.72
EV to Capital Employed
1.23
EV to Sales
1.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.78%
ROE (Latest)
-8.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 0.64% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.67 times
NET SALES(Q)
Highest at USD 190.17 MM
OPERATING PROFIT(Q)
Highest at USD 5.25 MM
OPERATING PROFIT MARGIN(Q)
Highest at 2.76 %
PRE-TAX PROFIT(Q)
Highest at USD -10.13 MM
NET PROFIT(Q)
Highest at USD -7.61 MM
EPS(Q)
Highest at USD -0.08
-5What is not working for the Company
ROCE(HY)
Lowest at -12.42%
DEBT-EQUITY RATIO
(HY)
Highest at 29.86 %
CASH AND EQV(HY)
Lowest at USD 323.74 MM
Here's what is working for NeoGenomics, Inc.
Net Sales
Highest at USD 190.17 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 5.25 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 2.76 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -10.13 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -7.61 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.08
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 4.67 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 0.64% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NeoGenomics, Inc.
Debt-Equity Ratio
Highest at 29.86 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at USD 323.74 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
